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The asexual stages of malaria parasites multiply within erythrocytes and are
released as merozoites to invade other erythrocytes. One goal ofvaccines against
this stage is to induce antibodies against merozoite surface antigens to block
erythrocyte invasion. Antibodies can inhibit erythrocyte invasion in vitro (1) and
provide protection against lethal infection in vivo (2).
A 140 kD merozoite surfaceprotein ofPlasmodium knowlesi, a monkey malaria,
was identified as a potential vaccine candidate for this model system (3). Anti-
bodies against this protein and its 143 kD precursor inhibit erythrocyte invasion
in vitro (4, 5). Immunity to the 143/140 kD protein conferred partial protection
in vivo in two offour monkeys immunized with purified antigens (5). Only these
two animals had circulating antibodies that inhibited erythrocyte invasion in
vitro. Parasites isolated from a protected animal, however, were no longer
inhibited by immune sera in vitro. The 143/140 kD antigens disappeared and
antigens of different molecular mass appeared (5). Since the challenge inoculum
was not cloned (6) and had been maintained in monkeys for many years after
isolation from an infected individual, we did not know if variants existed in the
inoculum or, alternatively, if the parasites were able to vary this antigen rapidly.
To resolve this question, we inoculated a cloned parasite into two monkeys
immunized with the 143/140 kD proteins. We describe the disappearance of
parasites bearing 143/140 kD proteins within less than one month in both
monkeys, and the appearance of parasites bearing new antigens of 72-160 kD
or no detectable antigen immunologically crossreactive with the original immu-
nogen.
Materials and Methods
Parasites.
￿
The Malaysian H strain ofP. knowlesi was used in this study(6). Two clones,
Pk1(A+) and Pk1(B+)1+, were derived from this parasite strain by micromanipulation (7).
PkI(B+)1+ was a clone derived from a variant population ofthe clone PkI(A+) (7).
To study the effect of immunity to the 143/140 kD antigens on P. knowlesi, we
inoculated a P. knowlesiclone, Pk1(A+), into two rhesus monkeys that had been immunized
with the 143/140 kD antigens. They had previously been infected with uncloned P.
knowlesi parasites (5) and cured oftheir infections before challenge.
Parasitizederythrocytes were maintained ascryopreservedstocks stored at -80°C until
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use . For biochemical studies, asexual erythrocytic stage parasites were maintained in
splenectomized monkeys . Monkeys were inoculated with 5 X 10 5 to 2 X 109 ring-stage
parasites intravenously . Monkeys with life-threatening parasitemias (>10%) were treated
with chloroquine hydrochloride (Aralen ; Sterling Drug, Inc., New York) .
ChronicP. knowlesi infection was induced in one monkey by administration of sufficient
chloroquine (20 to 40 mg in a single dose) to control the infection without totally
eliminating the parasites . After several such treatments a chronic infection ensued,
characterized by periodic recrudescent parasitemias .
Metabolic Labeling of Schizont Antigens .
￿
Schizont-infected blood was collected at para-
sitemias between 1-10% . For metabolic labeling studies, blood was collected when the
modal population among circulating schizonts had four to six nuclei . Parasite culture
conditions and metabolic labeling were described previously (4, 5) .
Labeled parasites were washed in serum-free RPMI 1640 and extracted in I% Triton
X-100, 10 mM Hepes, 50 ug/ml chymostatin, and 50 gg/ml leupeptin . All detergent
extractions were conducted at 4°C . Triton-soluble proteins were stored at -70°C until
use (5) . Immunoprecipitations, SDS-polyacrylamide gels, and fluorography were per-
formed as previously described (4, 5, 8) . Molecular weight standards were obtained from
Bio Rad Laboratories or Bethesda Research Laboratories, Gaithersburg, MD .
Invasion Inhibition Assay .
￿
Sera were tested for their effects on erythrocyte invasion as
previously described (4, 5) .
Antisera and Monoclonal Antibodies.
￿
The monoclonal antibodies and rhesus or rabbit
antisera against the 143/140 kD proteins used in the present study were previously
described (4, 5) .
Results
Stability of the 143/140 kD Protein During Chronic P. knowlesi Infections .
￿
P .
knowlesi parasitemia usually increases 10-fold each day until death in nonimmune
rhesus monkeys . If the infection is repeatedly suppressed with antimalarial drugs,
the animal becomes partially immune so that the untreated infection no longer
reaches life-threatening parasitemias . After immunization with the 143/140 kD
antigens, David et al . (5) found that an infected monkey developed a chronic
infection . Parasites obtained 45 d after infection expressed new antigens immu-
nologically crossreactive with the 143/140 kD antigens . In the present study, we
determined whether the 143/140 kD antigens vary during chronic infection in
the absence of specific immunity to the 143/140 kD proteins .
After inoculation ofa nonimmune monkey with PKI(A'), parasitemias reached
4.4, 14, and 3.3% during initial waves of parasitemia . These parasitemias were
suppressed with subcurative doses of chloroquine . A chronic infection then
ensued characterized by periodic recrudescences (Fig . 1) . We compared the
143/140 kD proteins of the inoculum with a recrudescent isolate taken several
months after infection .
Rabbit antiserum against the 143/140 kD proteins immunoprecipitated a
143/140 kD doublet from Pkl(A+) and breakdown products of 88/86 and 60
kD (Fig . 2, lane 1) . These smaller fragments are occasionally observed after
detergent extraction and immunoprecipitation . They may result from proteolysis
during handling . The identical antigens were observed in parasites recovered
from a chronic infection (Fig . 2, lane 2) . The 220 kD antigen (Fig . 2, lane 2) was
nonspecific, since it was also immunoprecipitated with nonimmune rabbit serum
(data not shown) . Previous studies had shown that processing of the 143 kD
precursor to the 140 kD product molecule occurs late in schizogony (5) . The
intensity difference between the 143/140 kD antigens (Fig . 2, lanes 1 and 2)KLOTZ ET AL.
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FIGURE 1.
￿
The course of parasitemia in a monkey inoculated with clone Pkl(A`) of P.
knowlesi. Chloroquine (Rx) was administered to suppress parasitemia. An isolate(asterisk) was
collectedon day 76 of infection.
reflects the degree of maturation of schizonts to merozoites during metabolic
labeling (5). Thus, the 143/140 kD proteins were identical in the isolate re-
covered from the chronic infection and the original inoculum.
In a previous study with the same cloned parasites ofP. knowlesi, we character-
ized a variant antigen unrelated tothe 143/140 kD proteins. This antigen, called
schizont-infected cell agglutination antigen (SICA),' is expressed on the surface
of infected erythrocytes. Antibody against one SICA type induced the parasite
to express other SICA types (7). The 143/140 kD antigens were unchanged in
parasites that had varied the erythrocyte surface antigen (data not shown).
We conclude that the 143/140 kD P. knowlesi proteins remain unchanged in
chronic infections and during antigenic variation in another protein, SICA.
Effects ofImmunity to the 143/140 kD Proteins on Expression ofthese Proteins in
Surviving Organisms.
￿
Two monkeys (1 and 4) that had been immunized with
the 143/140 kD proteins, and a control monkey were inoculated with cloned
parasites, PkI(A'). The control monkey developed a typical fulminant infection
and was cured of malaria (Fig. 3). The immunized monkeys controlled the
primary parasitemia. After 3 wk, monkey 4 developed a fulminant infection and
was cured. The other monkey (monkey 1) developed a chronic infection with
multiple recrudescences ofparasitemia occurring over several months, and was
then drug cured.
Antibodies against the 143/140 kD proteins inhibit erythrocyte invasion in
vitro by merozoites of the parental clone, Pk1(A+). The antibodies had no effect
on invasion by parasites recovered on day 30 in monkey 4 or by parasites
recovered on day 87 during the chronic infection in monkey 1 (Table 1). Normal
invasion despite antibodies against the 143/140 kD proteins correlated with
change in the 143/140 kD proteins in these parasites.
Parasite isolates were obtained during several peaks ofparasitemia in the two
monkeys (two for monkey 4 and five for monkey 1). Metabolically-labelled
parasite antigens obtained from each isolate wereimmunoprecipitated with rabbit
' Abbreviation used in this paper.
￿
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FIGURE 2 . Fluorograph of SDS-PAGE (5-15% linear polyacrylamide gradient) of [s 5S]-
methionine-labeled antigens immunoprecipitated by rabbit antiserum against the 143/140 kD
antigens . Clone PkI(A+) (lane 1), the parasite inoculated into the monkey described in Fig . 1,
was compared with the isolate obtained on day 76 (lane 2) . Arrows mark the 143/140 kD
proteins and their cleavage products . BOB, bromophenol blue dye front . Molecularmass shown
in kD .
antiserum against the 143/140 kD proteins . Parasites recovered 8 d after
challenge from monkey 1 retained the original 143/140 kD antigens . The
143/140 kD proteins had disappeared by day 30 (data not shown) . New proteins
were immunoprecipitated from parasites recovered from days 59, 87, and 102.
Proteins immunoprecipitated from parasites recovered on day 87 (Fig . 4) are
identical to those immunoprecipitated on days 59 and 102 (data not shown) . The
new antigens reactive with rabbit antiserum against the 143/140 kD proteins
had molecular masses of 160/155, 115/113, and 87/85 kD (Fig . 4) . In monkey
4, the 143/140 kD proteins are present on day 8 and had disappeared by day
30 .
Clones of Parasites from Monkey 4 .
￿
The isolate recovered on day 30 from
monkey 4 during the first recrudescence (hereafter called VI) was cloned by
micromanipulation and inoculated into five monkeys . Parasites from the five
clones were recovered from each of the five monkeys . Antigens from each isolatea
a
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FIGURE 3 .
￿
The course of parasitemia in monkeys inoculated with clone Pkl(A'). Control
monkey (triangles) and two monkeys previously immunized with the 143/140 kD proteins
(monkey 1, open circles and monkey 4, filled circles). An asterisk marks thetime points at which
a parasite isolate was collected.
TABLE I
Effect ofImmune Sera on Erythrocyte Invasion by a Clone of
P. knowlesi, Pkl(A'), and Two Uncloned Variants (VI and V2)
of this Clone
* V1 was obtained from monkey 4 on day 30 of infection. V2 were
obtained from monkey 1 on day 87 of infection.
Preimmune sera refers to sera collected before immunization with
purified antigens. Immune sera were collected after repeated immuni-
zations (6).
1 Numbersarepercentage of newly-invaded erythrocytes.
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were metabolicallylabeled and immunoprecipitated withrabbit antiserum against
the 143/140 kD proteins. Two clones (Vla and Vlb) expressed proteins of 76
and 72 kD and three clones (VIc, Vld, Vle) expressed no protein crossreactive
with rabbit antiserum against the 143/140 kD proteins (Fig. 5). Proteins of
>300, 210, 100, and 45 kD are background bands, as they are seen in immu-
noprecipitates with preimmune sera (Fig. 5).
To determine whether the new 76/72 kD antigens of clones Vla and Vlb
retained all antigenic determinants identified in the parental molecules by
monoclonal antibodies, immunoprecipitations were performed using a panel of
monoclonal antibodies against the 143/140 kD proteins. The 76 kD protein was
immunoprecipitated by two monoclonal antibodies (1005-B7 and 1019-C3) and
not by three others (1001-E12, 1002-6E8, and 1038-6133). Two other clones,
V1c and V1d, which did not react with rabbit antiserum against the 143/140
kD proteins expressed no new antigens reactive with any of the monoclonal
antibodies.
Monkey Serum
Source of
Pkl(A')
schizonts for
V1*
invasion
V2*
1 Preimmune$ 28.11 10.3 32.6
Immune 4.2 10.8 35.5
4 Preimmune 23.4 8.6 30.6
Immune 4.6 9.7 31 .0364
￿
VACCINATION-INDUCED VARIATION OF MALARIA ANTIGEN
FIGURE 4.
￿
Fluorograph of SDS-PAGE (5-12.5% linear polyacrylamide gradient) of ["Sl-
methionine-labeled antigens immunoprecipitated by rabbit antiserum against the 143/140 kD
proteins. Lane 1, Pkl(A+), the parasite inoculated into monkey 1 (see Fig . 3) ; lane 2, parasites
isolated from monkey 1 on day 8 ; lane 3, parasites isolated from monkey 1 on day 87 . Arrows
identify the specific immunoprecipitates and the 143/140 kD proteins . BOB, bromophenol
blue dye front. Molecular mass shown in kD .
The 140 kD protein of parental clone PkI(A') is readily radiolabeled with I25I
on intact merozoites as described previously (3) . The 140kD protein was missing
from the surface radioiodinated merozoites from the five clones and no new
proteins were labeled. Immunoprecipitation with antisera against the 143/140
kD proteins failed to precipitate any proteins from the clones (data not shown) .
Despite the presence of [s5S]methionine labeled antigens in clones V 1a andV1 b,
no radioiodinated antigens were detected . It is conceivable that the 76 kD
protein is not transported to the merozoite surface or once transported to the
merozoite surface, the 76 kD protein fails to attach . It is also possible that the
76 kD protein lacks an accessible tyrosine for iodination .
Invasion of Erythrocytes by Parasites Apparently Lacking the 143/140 kD Pro-
teins. Parasite clone VIc expresses no detectable 143/140 kD proteins . We
sought to determine if the absence of these proteins would alter the erythrocyte
ligand requirements for invasion . Duffy blood group-negative human erythro-
cytes and chymotrypsin-treated human erythrocytes are refractory to invasionKLOTZ ET AL.
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FIGURE 5.
￿
Fluorograph of SDS-PAGE (5-12.5% linear polyacrylamide gradient) of [15S]-
methionine-labeled antigens from Pk1(A+ ),V 1 and five clones from V 1 . The letter A denotes
immune rabbitserum against the 143/140 kD antigens,A., preimmune serum . Arrows identify
specific immunoprecipitates . BOB, bromophenol blue dye front. Molecular mass shown in kD .
by P. knowlesi (9) . We found Duffy-negative and chymotrypsin-treated human
erythrocytes were refractory to invasion by clone Vlc . Trypsin-treated human
erythrocytes are equally invaded by P. knowlesi merozoites from Pk1(A+) or V1c .
Therefore we can identify no differences in requirements for invasion between
the variant V 1 c and those described previously .
Discussion
Under immune pressure, cloned parasites underwent rapid change, such that
antibody no longer blocked their invasion of erythrocytes . This report describes
these events and begins to explore the biochemical basis for the parasite's evasion
of the immune response . Two monkeys had been immunized with a 140 kD
merozoite surface protein (5) . This protein was chosen for vaccination trials
because monoclonal antibodies against this protein inhibited invasion in vitro (4).
The 143/140 kD proteins were also chosen because of their presumed stability
in vivo . The 143/140 kD proteins are unchanged during chronic infection over
several months duration .366
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In the present study, the monkeys were inoculated with cloned parasites. The
initial wave of parasitemia reached apeak of ^-3.5% and then fell to undetectable
levels. During the next wave of parasitemia in both monkeys, the 143/140 kD
proteins had disappeared. The only previous description of variation in antigenic
type from cloned malaria parasites was the SICA antigen of P. knowlesi (7) and
its probable analogue in P. falciparum with uncloned parasites(10). With antibody
against the SICA antigen of the inoculum, the SICA antigen changes rapidly to
a new type. During the initial rise in parasitemia, new variants appear, and
parasitemia increases as rapidly in immune animals as in animals without anti-
SICA antibody (7). Thus, anti-SICA antibody probably induces variation; selec-
tion does not appear to be involved with antigenic variation of SICA types. In
contrast, the 140 kD merozoite protein does not vary during the first wave of
parasitemia. The variants are first observed in the second wave of parasitemia.
Because antibodies against the 143/140 kD proteins inhibit invasion, selection
of variants is the likely mechanism. If the parasitemia during the first wave
reaches a peak of 3% in a 3-kg monkey, there are -2 X 10'° parasites from
which to select mutants. The variant antigens differ in molecular mass (165-76
kD), and have lost some or all epitopes recognized by monoclonal antibodies
against the 143/140 kD antigens. It is unknown whether the variants have new
antigenic epitopes or if some clones express a unique antigen.
Although we do not know the function of the 143/140 kD proteins of P.
knowlesi, it is surprising that parasites apparently lacking the merozoite surface
protein (V1 c,d,e) can invade in vitro and multiply effectively in vivo. The
143/140 kD proteins may not be involved in invasion and may not be critical for
parasite survival. Alternatively, unrecognized mutations may have replaced the
function of the 143/140 kD proteins. For example, there is variation in the
requirement for erythrocyte ligands among various isolates ofP. falciparum (11).
Some require sialic acid on the erythrocyte for invasion; others can invade
effectively through sialic acid-independent mechanisms. In the present study,
we could detect no differences in the ligand requirements for invasion by variant
parasites, although some undetected alteration in the invasion sequence may
have occurred.
Under selective pressure where antibody against a particular protein leads to
death of the parasite (e.g., through vaccination), there may be loss of certain
antigenic determinants . Such events could occur from expression of other
analogous genes within a repertoire, or from multiple pointmutations, rearrange-
ments, nonsense mutations, or deletions within a gene. The chance for survival
of such mutants is increased if the gene is not crucial for survival .
Summary
Immunity to 143/140 kD schizont antigens of a monkey malaria, Plasmodium
knowlesi, provides partial protection to lethal malaria infection in rhesus monkeys
challenged with uncloned parasites. To determine the capacity of a cloned
parasite to generate variants of the 143/140 kD antigens, immunized monkeys
were challenged with a clone of P. knowlesi. Parasites recovered 8 d after
inoculation with a cloned parasite retained the 143/140 kD antigens. Parasites
recovered 30 d after challenge had undergone changes in the 143/140 kDKLOTZ ET AL.
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antigens. Antibodies that block erythrocyte invasion in vitro of the inoculum
parasites did not inhibit invasion of erythrocytes by two isolates recovered from
the immunized monkeys . An isolate from one monkey recovered on day 30
contained clones expressing new 76/72 kD antigens reactive with rabbit anti-
serum against the 143/140 kD proteins, and other clones expressing no antigens
crossreactive with antisera against the 143/140 kD proteins. An isolate from
another monkey obtained 59 d after challenge expressed new antigens of
160/155, 115/113, and 87/85 kD . Using monoclonal antibodies, we found that
epitopes were lost from the variant proteins, but we were unable to determine
whether new epitopes had appeared. We conclude that clones of P. knowlesi can
rapidly vary antigenic determinants on the 143/140 kD proteins in animals
immunized with these antigens.
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